BEAT HeartBeam, Inc.
0.5430USD-7.02%Mkt Cap: 30.60M $P/E: —1d ago
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facilit…
Industry Peers
Health Information Services$45.74BUSDP/E 46.3
$12.69BUSD
$12.62BUSDP/E 56.5
$7.90BUSDP/E 32.3
$7.60BUSDP/E 33.2
$4.94BUSDP/E 36.8
$4.94BUSDP/E 32.6
$4.29BUSD
$2.59BUSDP/E 96.7
$2.04BUSD
$1.61BUSDP/E 41.9
$1.37BUSD
$1.28BUSDP/E 87.0
$1.11BUSDP/E 65.0
$1.01BUSD
$982.13MUSDP/E 44.6
$651.74MUSDP/E 61.8
$608.66MUSD
$592.92MUSD
$521.70MUSDP/E 29.4
| Headline | Source | Time |
|---|---|---|
Older | ||
 HeartBeam, Inc. Q2 2026 Earnings Call Summary Moby summary of HeartBeam, Inc.'s Q2 2026 earnings call | ||
HeartBeam Inc (BEAT) (Q2 2026) Earnings Call Highlights: FDA Submission Advances and Commercial ... HeartBeam Inc (BEAT) progresses its regulatory pathway with a 510(k) pre-submission while expanding commercial agreements and extending its cash runway into 2027. | ||